drugset / Trial / NCT04800107

Effect of Highly Bioavailable Curcumin on Subjective Tinnitus

NCT04800107

Unknown 110 enrolled Henry Ford Health System
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the effectiveness of highly bioavailable curcumin in suppressing subjective tinnitus based on pre- and post-treatment evaluations using the validated Tinnitus Functional Index (TFI) and Tinnitus Handicap Inventory (THI) surveys.

Timeline

Start
2021-01-06
Primary completion
2025-12-31
Completion
2025-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Boswellia Traditional medicine (herbal / TCM) 250 mg Oral
Subject Curcumin Small molecule 500 mg Oral

Indications